Variant · Snv
BCKDHB NM_183050.4(BCKDHB):c.196+1G>A
CI-VAR-00306899Explore in graph →NM_183050.4:c.196+1G>AClinVar 2680145 rs1554181203
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 2680145 | Likely pathogenic | criteria provided, multiple submitters, no conflicts | 2 | Maple syrup urine disease; Ovarian serous cystadenocarcinoma; Maple syrup urine disease type 1B | germline | 3 | Sep 08, 2025 | clinvar |